Literature DB >> 29312491

MicroRNA-34a promotes cell cycle arrest and apoptosis and suppresses cell adhesion by targeting DUSP1 in osteosarcoma.

Liu Gang1,2, Li Qun3, Wei-Dong Liu2, Yong-Sheng Li4, Yao-Zeng Xu1, Dong-Tang Yuan2.   

Abstract

MicroRNAs are often deregulated in most cancer types and have important functions in carcinogenesis and cancer progression. Here, we studied the function of microRNA-34 (miR-34a) in osteosarcoma MG63 and U-2OS cells by expressed with pre-miR-34a, anti-miR-34a and corresponding negative controls, respectively. Cells proliferation, cell cycle and apoptosis was measured by MTT and flow cytometry assay. The effect of miR-34a on DUSP1 expression was evaluated by luciferase assays, real-time PCR and western blot assay. The data showed that miR-34a reduced the proliferation of MG63 cells through prompting cell cycle arrest at G0/G1 phase, cell apoptosis, and suppressed cell adhesion ability. Whereas anti-miR-34a increases U-2OS cell proliferation by preventing cell apoptosis, and promotes cell adhesion. Finally, we identified Dual-specificity phosphatase 1 (DUSP1) as the target gene of miR-34a in osteosarcoma cells and confirmed that DUSP1 enhanced the proliferation through inhibiting cell cycle arrest at G0/G1 phase and apoptosis, and inhibits the decreased cell adhesion induced by miR-34a. However, inhibition of DUSP1 resulted in substantially decreased proliferation and adhesion, and cell cycle arrest in G0/G1 phase and cell apoptosis similar to that observed with miR-34a in U-2OS cells. Our findings find out an important function of miR-34a as a novel tumor-suppressor in osteosarcoma pathogenesis through inhibition of DUSP1.

Entities:  

Keywords:  DUSP1; G0-G1 phase; adhesion; miR-34a; osteosarcoma

Year:  2017        PMID: 29312491      PMCID: PMC5752889     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  31 in total

1.  Impact of microRNA-375 and its target gene SMAD-7 polymorphism on susceptibility of colorectal cancer.

Authors:  Olfat Gamil Shaker; Shereen Rashad Mohammed; Asmaa Mohammed Mohammed; Zeinab Mahmoud
Journal:  J Clin Lab Anal       Date:  2017-04-04       Impact factor: 2.352

2.  MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.

Authors:  Luana Joyce Silva Lopes; Francine Tesser-Gamba; Antônio Sérgio Petrilli; Maria Teresa de Seixas Alves; Reynaldo Jesus Garcia-Filho; Silvia Regina Caminada Toledo
Journal:  Mol Carcinog       Date:  2017-02-15       Impact factor: 4.784

3.  Osthole Induces Cell Cycle Arrest and Inhibits Migration and Invasion via PTEN/Akt Pathways in Osteosarcoma.

Authors:  Lu Wang; Lei Yang; Ying Lu; Yingzhun Chen; Tianhua Liu; Yanli Peng; Yuhong Zhou; Yang Cao; Zhenggang Bi; Tianyi Liu; Zhenhong Liu; Hongli Shan
Journal:  Cell Physiol Biochem       Date:  2016-05-17

Review 4.  Dual-specificity MAP kinase phosphatases (MKPs) and cancer.

Authors:  Stephen M Keyse
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

5.  Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program.

Authors:  Lisa Mirabello; Rebecca J Troisi; Sharon A Savage
Journal:  Cancer       Date:  2009-04-01       Impact factor: 6.860

6.  MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma.

Authors:  Xufu Wei; Chengyong Tang; Xiuxian Lu; Rui Liu; Mi Zhou; Diao He; Daofeng Zheng; Chao Sun; Zhongjun Wu
Journal:  Oncotarget       Date:  2015-07-30

7.  Retaining MKP1 expression and attenuating JNK-mediated apoptosis by RIP1 for cisplatin resistance through miR-940 inhibition.

Authors:  Qiong Wang; Shaoqing Shi; Weiyang He; Mabel T Padilla; Lin Zhang; Xia Wang; Bin Zhang; Yong Lin
Journal:  Oncotarget       Date:  2014-03-15

8.  MicroRNA-199a-3p and microRNA-34a regulate apoptosis in human osteosarcoma cells.

Authors:  Ye Tian; Ying-Ze Zhang; Wei Chen
Journal:  Biosci Rep       Date:  2014-08-06       Impact factor: 3.840

9.  MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.

Authors:  Mingguang Lai; Gang Du; Ruiyue Shi; Jun Yao; Genhua Yang; Yue Wei; Dingguo Zhang; Zhenglei Xu; Ru Zhang; Yingxue Li; Zicheng Li; Lisheng Wang
Journal:  Mol Med Rep       Date:  2015-01-12       Impact factor: 2.952

10.  MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.

Authors:  Koichiro Minami; Kohei Taniguchi; Nobuhiko Sugito; Yuki Kuranaga; Teruo Inamoto; Kiyoshi Takahara; Tomoaki Takai; Yuki Yoshikawa; Satoshi Kiyama; Yukihiro Akao; Haruhito Azuma
Journal:  Oncotarget       Date:  2017-05-16
View more
  16 in total

1.  Layer-by-layer assembled PLGA nanoparticles carrying miR-34a cargo inhibit the proliferation and cell cycle progression of triple-negative breast cancer cells.

Authors:  Chintan H Kapadia; Stephen A Ioele; Emily S Day
Journal:  J Biomed Mater Res A       Date:  2019-11-26       Impact factor: 4.396

2.  Potential biomarkers of HCC based on gene expression and DNA methylation profiles.

Authors:  Chao Meng; Xiaomin Shen; Wentao Jiang
Journal:  Oncol Lett       Date:  2018-06-26       Impact factor: 2.967

3.  MicroRNAs are inappropriate for characterising hearing impairment in mitochondrial disorders.

Authors:  Josef Finsterer; Sinda Zarrouk-Mahjoub
Journal:  Orphanet J Rare Dis       Date:  2018-05-31       Impact factor: 4.123

Review 4.  MicroRNA-34 family: a potential tumor suppressor and therapeutic candidate in cancer.

Authors:  Lu Zhang; Yi Liao; Liling Tang
Journal:  J Exp Clin Cancer Res       Date:  2019-02-04

5.  Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study.

Authors:  Despoina Kalapanida; Flora Zagouri; Maria Gazouli; Eleni Zografos; Constantine Dimitrakakis; Spyridon Marinopoulos; Aris Giannos; Theodoros N Sergentanis; Efstathios Kastritis; Evangelos Terpos; Meletios-Athanasios Dimopoulos
Journal:  Oncotarget       Date:  2018-12-11

6.  MicroRNA-372 functions as a tumor suppressor in cell invasion, migration and epithelial-mesenchymal transition by targeting ATAD2 in renal cell carcinoma.

Authors:  Shiqi Ji; Xiaolin Su; Haijian Zhang; Zhixing Han; Yuqian Zhao; Qingjun Liu
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967

Review 7.  Non-Coding RNAs in Pediatric Solid Tumors.

Authors:  Christopher M Smith; Daniel Catchpoole; Gyorgy Hutvagner
Journal:  Front Genet       Date:  2019-09-20       Impact factor: 4.599

8.  A comprehensive analysis for associations between multiple microRNAs and prognosis of osteosarcoma patients.

Authors:  Wen Yang; Yu-Bin Qi; Meng Si; Yong Hou; Lin Nie
Journal:  PeerJ       Date:  2020-01-20       Impact factor: 2.984

9.  Siglec-15 Promotes Tumor Progression in Osteosarcoma via DUSP1/MAPK Pathway.

Authors:  Meng-Ke Fan; Guo-Chuan Zhang; Wei Chen; Li-Li Qi; Ming-Fang Xie; Yue-Yao Zhang; Ling Wang; Qi Zhang
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244

10.  Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.

Authors:  Guangchao Duan; Chuanlin Zhang; Changke Xu; Chao Xu; Lei Zhang; Yan Zhang
Journal:  Int J Oncol       Date:  2018-10-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.